Global Chondrosarcoma Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 15962

Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of American Cancer Society, occurrence of chondrosarcoma in patients younger than 20 years is less than 5%.  Chondrosarcoma mainly affects the cartilage of arms, ribs, pelvis, and scapula and rarely found in trachea, breast and other parts of the body showing presence of cartilage tissue. Chondrosarcoma patients do not show any symptoms at an early stage hence, it can only be diagnosed in the late stage of a tumor when it shows fracture and bony bump at the tumor site. Diagnosis of chondrosarcoma can be done using radiography (X-Ray), computerized tomography (CT scan) or magnetic resonance imaging (MRI). Unlike other cancers chondrosarcoma is resistant to chemotherapy and radiation therapy and can primarily be treated with surgery. Surgical procedures for chondrosarcoma treatment involve limb sparing operations, complete surgical ablation and amputation in certain cases.
Increasing prevalence of osteosarcoma can ultimately influence the growth of global chondrosarcoma treatment market. According to Cancer Network Journal the incidence of osteosacrcoma in the U.S. is approximately 800 cases per year. Other factors responsible for growth of global chondrosarcoma treatment market include growing prevalence of genetic diseases.
In 2018, the global Chondrosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Chondrosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chondrosarcoma Treatment development in United States, Europe and China.

The key players covered in this study
Hoffmann-La Roche
AEterna Zentaris
Acorn Research
Agios Pharmaceuticals
Infinity Pharmaceuticals
...

Market segment by Type, the product can be split into
Surgical Treatment
Chemotherapy
Radiation Therapy

Market segment by Application, split into
Hospitals
Multispecialty Clinics
Cancer Treatment Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Chondrosarcoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Chondrosarcoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chondrosarcoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chondrosarcoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgical Treatment
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.5 Market by Application
1.5.1 Global Chondrosarcoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Multispecialty Clinics
1.5.4 Cancer Treatment Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chondrosarcoma Treatment Market Size
2.2 Chondrosarcoma Treatment Growth Trends by Regions
2.2.1 Chondrosarcoma Treatment Market Size by Regions (2014-2025)
2.2.2 Chondrosarcoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Chondrosarcoma Treatment Market Size by Manufacturers
3.1.1 Global Chondrosarcoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Chondrosarcoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chondrosarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chondrosarcoma Treatment Key Players Head office and Area Served
3.3 Key Players Chondrosarcoma Treatment Product/Solution/Service
3.4 Date of Enter into Chondrosarcoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chondrosarcoma Treatment Market Size by Type (2014-2019)
4.2 Global Chondrosarcoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Chondrosarcoma Treatment Market Size (2014-2019)
5.2 Chondrosarcoma Treatment Key Players in United States
5.3 United States Chondrosarcoma Treatment Market Size by Type
5.4 United States Chondrosarcoma Treatment Market Size by Application

6 Europe
6.1 Europe Chondrosarcoma Treatment Market Size (2014-2019)
6.2 Chondrosarcoma Treatment Key Players in Europe
6.3 Europe Chondrosarcoma Treatment Market Size by Type
6.4 Europe Chondrosarcoma Treatment Market Size by Application

7 China
7.1 China Chondrosarcoma Treatment Market Size (2014-2019)
7.2 Chondrosarcoma Treatment Key Players in China
7.3 China Chondrosarcoma Treatment Market Size by Type
7.4 China Chondrosarcoma Treatment Market Size by Application

8 Japan
8.1 Japan Chondrosarcoma Treatment Market Size (2014-2019)
8.2 Chondrosarcoma Treatment Key Players in Japan
8.3 Japan Chondrosarcoma Treatment Market Size by Type
8.4 Japan Chondrosarcoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Chondrosarcoma Treatment Market Size (2014-2019)
9.2 Chondrosarcoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Chondrosarcoma Treatment Market Size by Type
9.4 Southeast Asia Chondrosarcoma Treatment Market Size by Application

10 India
10.1 India Chondrosarcoma Treatment Market Size (2014-2019)
10.2 Chondrosarcoma Treatment Key Players in India
10.3 India Chondrosarcoma Treatment Market Size by Type
10.4 India Chondrosarcoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Chondrosarcoma Treatment Market Size (2014-2019)
11.2 Chondrosarcoma Treatment Key Players in Central & South America
11.3 Central & South America Chondrosarcoma Treatment Market Size by Type
11.4 Central & South America Chondrosarcoma Treatment Market Size by Application

12 International Players Profiles
12.1 Hoffmann-La Roche
12.1.1 Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chondrosarcoma Treatment Introduction
12.1.4 Hoffmann-La Roche Revenue in Chondrosarcoma Treatment Business (2014-2019)
12.1.5 Hoffmann-La Roche Recent Development
12.2 AEterna Zentaris
12.2.1 AEterna Zentaris Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chondrosarcoma Treatment Introduction
12.2.4 AEterna Zentaris Revenue in Chondrosarcoma Treatment Business (2014-2019)
12.2.5 AEterna Zentaris Recent Development
12.3 Acorn Research
12.3.1 Acorn Research Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chondrosarcoma Treatment Introduction
12.3.4 Acorn Research Revenue in Chondrosarcoma Treatment Business (2014-2019)
12.3.5 Acorn Research Recent Development
12.4 Agios Pharmaceuticals
12.4.1 Agios Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chondrosarcoma Treatment Introduction
12.4.4 Agios Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2014-2019)
12.4.5 Agios Pharmaceuticals Recent Development
12.5 Infinity Pharmaceuticals
12.5.1 Infinity Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chondrosarcoma Treatment Introduction
12.5.4 Infinity Pharmaceuticals Revenue in Chondrosarcoma Treatment Business (2014-2019)
12.5.5 Infinity Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details